PMID- 10669634 OWN - NLM STAT- MEDLINE DCOM- 20000303 LR - 20190831 IS - 1079-5642 (Print) IS - 1079-5642 (Linking) VI - 20 IP - 2 DP - 2000 Feb TI - Convergence of redox-sensitive and mitogen-activated protein kinase signaling pathways in tumor necrosis factor-alpha-mediated monocyte chemoattractant protein-1 induction in vascular smooth muscle cells. PG - 385-91 AB - Monocyte chemoattractant protein-1 (MCP-1) is an important component of the inflammatory response of the vessel wall and has been shown to be regulated by cytokines, such as tumor necrosis factor-alpha (TNF-alpha). However, the precise signaling pathways leading to MCP-1 induction have not been fully elucidated in vascular smooth muscle cells (VSMCs). Cytokine signal transduction involves protein kinases as well as reactive oxygen species (ROS). The relation between these 2 factors is not clear. In this study, we show that TNF-alpha induces a parallel phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2) and p38 mitogen-activated protein kinase (p38MAPK) and increases MCP-1 mRNA expression in cultured VSMCs. Inhibition of ERK1/2 but not p38MAPK caused a partial attenuation of MCP-1 induction (43+/-10% inhibition). Incubation of VSMCs with multiple antioxidants (diphenylene iodonium, liposomal superoxide dismutase, catalase, N-acetylcysteine, dimethylthiourea, and pyrrolidine dithiocarbamate) had no effect on TNF-alpha-mediated MCP-1 upregulation. However, simultaneous blockade of the ERK1/2 and ROS pathways by using PD098059 combined with diphenylene iodonium or N-acetylcysteine potently enhanced the ability of MAPK kinase inhibitors to abrogate MCP-1 mRNA expression (100+/-2% inhibition). Thus, parallel ROS-dependent and ERK1/2-dependent pathways converge to regulate TNF-alpha-induced MCP-1 gene expression in VSMCs. These data unmask a complex but organized integration of ROS and protein kinases that mediates cytokine-induced vascular inflammatory gene expression. FAU - De Keulenaer, G W AU - De Keulenaer GW AD - Division of Cardiology, Emory University School of Medicine, Atlanta, GA 30322, USA. FAU - Ushio-Fukai, M AU - Ushio-Fukai M FAU - Yin, Q AU - Yin Q FAU - Chung, A B AU - Chung AB FAU - Lyons, P R AU - Lyons PR FAU - Ishizaka, N AU - Ishizaka N FAU - Rengarajan, K AU - Rengarajan K FAU - Taylor, W R AU - Taylor WR FAU - Alexander, R W AU - Alexander RW FAU - Griendling, K K AU - Griendling KK LA - eng GR - HL-58863/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Arterioscler Thromb Vasc Biol JT - Arteriosclerosis, thrombosis, and vascular biology JID - 9505803 RN - 0 (Chemokine CCL2) RN - 0 (Reactive Oxygen Species) RN - 0 (Tumor Necrosis Factor-alpha) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinases) SB - IM MH - Animals MH - Cells, Cultured MH - Chemokine CCL2/*metabolism MH - Mitogen-Activated Protein Kinases/*physiology MH - Muscle, Smooth, Vascular/cytology/drug effects/*metabolism MH - Oxidation-Reduction MH - Rats MH - Reactive Oxygen Species/metabolism MH - Signal Transduction/*physiology MH - Tumor Necrosis Factor-alpha/pharmacology/*physiology MH - Up-Regulation EDAT- 2000/02/17 09:00 MHDA- 2000/03/11 09:00 CRDT- 2000/02/17 09:00 PHST- 2000/02/17 09:00 [pubmed] PHST- 2000/03/11 09:00 [medline] PHST- 2000/02/17 09:00 [entrez] AID - 10.1161/01.atv.20.2.385 [doi] PST - ppublish SO - Arterioscler Thromb Vasc Biol. 2000 Feb;20(2):385-91. doi: 10.1161/01.atv.20.2.385.